ESRD
97
5
5
60
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
15 trials with published results (15%)
Research Maturity
60 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.2%
8 terminated out of 97 trials
88.2%
+1.6% vs benchmark
21%
20 trials in Phase 3/4
25%
15 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 60 completed trials
Clinical Trials (97)
Ultrasound Guidance Intercostobrachial Nerve Block in AVF Superficialization
Peritoneal Dialysis Registration System (PERSIST)
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Safety and Efficacy of Canagliflozin in Advanced CKD
TESTING -ON Post-Trial ObservatioNal Cohort Study
A Culturally Targeted Transplant Program
VasQ External Support for Arteriovenous Fistula
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
Repletion of Ergothioneine in Patients With Kidney Failure
Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Adding Urea to the Final Dialysis Fluid
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
Interventions Made to Preserve Cognitive Function
The Study of Efficacy and Safety of Automated PD in Urgent Start Dialysis
Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis
Early Feasibility Study to Evaluate the Safety and Efficacy of PAK HD in ESRD Patients